v3.24.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 20,729,983 $ 10,867,050
Accounts receivable 242,617 72,609
Prepaid expenses 521,370 784,920
Other current assets 360,125 447,566
Total Current Assets 21,854,095 12,172,145
Property and equipment, net 5,523,013 5,393,012
Operating lease right-of-use assets 549,504 619,392
Intangible assets, net 23,886 110,505
Total Assets 27,950,498 18,295,054
Current Liabilities    
Accounts payable 3,211,287 3,043,008
Accrued liabilities 3,928,761 2,872,247
Deferred revenue 23,000,000 10,000,000
Management and directors' fees payable 59,625 71,119
Current portion of long-term debt 1,207,007 1,066,700
Warrant liability 126,649 0
Current portion of financing lease liabilities 48,570 46,014
Current portion of operating lease liabilities 199,323 245,163
Current portion of grant repayable 55,855 41,836
Total Current Liabilities 31,837,077 17,386,087
Long-term debt, net of current portion 3,624,860 2,779,240
Finance lease liabilities, net of current portion 400,022 436,132
Operating lease liabilities, net of current portion 378,054 400,091
Grant repayable, net of current portion 422,707 420,466
Total Liabilities 36,662,720 21,422,016
Stockholders' Deficit    
Common stock Authorized: 100,000,000 shares of common stock, at $0.001 par value Issued and outstanding: 81,898,321 shares and 57,873,379 shares, respectively 81,898 57,873
Additional paid-in capital 194,448,414 164,397,468
Accumulated other comprehensive income 243,940 227,097
Accumulated deficit (202,576,507) (167,257,429)
Total VolitionRx Limited Stockholders' Deficit (7,802,255) (2,574,991)
Non-controlling interest (909,967) (551,971)
Total Stockholders' Deficit (8,712,222) (3,126,962)
Total Liabilities and Stockholders' Deficit $ 27,950,498 $ 18,295,054

Source